Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

China flag China · Delayed Price · Currency is CNY
108.38
+6.66 (6.55%)
Sep 5, 2025, 2:45 PM CST
6.55%
Market Cap38.32B
Revenue (ttm)6.30B
Net Income (ttm)1.07B
Shares Out359.15M
EPS (ttm)2.98
PE Ratio36.35
Forward PE30.83
Dividend1.10 (1.02%)
Ex-Dividend DateJun 26, 2025
Volume10,732,836
Average Volume10,735,276
Open103.40
Previous Close101.72
Day's Range100.80 - 109.10
52-Week Range59.90 - 125.50
Beta0.23
RSI53.21
Earnings DateAug 26, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,595
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002821
Full Company Profile

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial Statements

News

There is no news available yet.